The role of autologous haematopoetic stem cell transplantation in post-remission therapy of AML

被引：0
|
作者：
Durakovic, N. [1 ]
Batinic, J. [1 ]
Sertic, D. [2 ]
Bojanic, I. [2 ]
Batinic, D. [1 ]
Golubic-Cepulic, B. [2 ]
Nemet, D. [1 ]
机构：
[1] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
[2] Clin Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S392 / S393
页数：2
相关论文
共 50 条
  • [41] DOES ALLOGENEIC HSCT PLAY A ROLE IN FIRST-LINE POST-REMISSION THERAPY FOR AML PATIENTS WITH T(8;21) IN FIRST COMPLETE REMISSION?
    Zhu, H. -H.
    Zhang, X. -H.
    Jiang, H.
    Liu, D. -H.
    Chen, H.
    Jiang, Q.
    Xu, L. -P.
    Lu, J.
    Han, W.
    Bao, L.
    Wang, Y.
    Chen, Y. -H.
    Lu, X. -J.
    Wang, J. -Z.
    Wang, F. -R.
    Qin, Y. -Z.
    Lai, Y-Y.
    Liu, R. -R.
    Liu, K. -Y.
    Jiang, B.
    Huang, X. -J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S325 - S325
  • [42] Time to Count Recovery after Post-Remission Chemotherapy in AML Patients
    Paras, Gabrielle
    Othus, Megan
    Shaw, Carole M.
    Russell, Katie
    Halpern, Anna B.
    Appelbaum, Jacob S.
    Hendrie, Paul C.
    Walter, Roland B.
    Percival, Mary-Elizabeth M.
    BLOOD, 2022, 140 : 6080 - 6081
  • [43] AUTOLOGOUS HEMATOPOEITIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST OR SECOND REMISSION
    Naqvi, H.
    John, V
    Devoe, C.
    Kiner, B.
    Kolitz, J.
    Allen, S.
    Gissinger, D.
    Cannon, M.
    Fitzgerald, E.
    Klocke, J.
    Bayer, R-L
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 39 - 39
  • [44] Retrospective analysis of post-remission modalities in AML patients with normal karyotype
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Cho, Yoon Young
    Moon, Joon Ho
    Ahn, Byung Min
    Kim, Shi Nae
    BLOOD, 2007, 110 (11) : 132B - 132B
  • [45] Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years
    Heini, Alexander D.
    Berger, Martin D.
    Seipel, Katja
    Taleghani, Behrouz Mansouri
    Baerlocher, Gabriela M.
    Leibundgut, Kurt
    Banz, Yara
    Novak, Urban
    Pabst, Thomas
    LEUKEMIA RESEARCH, 2017, 53 : 28 - 34
  • [46] Remission of Autoimmune Hepatitis Following Autologous Stem Cell Transplantation
    Prenatt, Zarian
    Shupp, Brittney
    Stoll, Lisa
    Liaquat, Hammad
    Geme, Berhanu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2021 - S2022
  • [47] Complete remission of scleromyxedema following autologous stem cell transplantation
    Feasel, AM
    Donato, ML
    Duvic, M
    ARCHIVES OF DERMATOLOGY, 2001, 137 (08) : 1071 - 1072
  • [48] Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
    Luxin Yang
    Yamin Tan
    Jimin Shi
    Yanmin Zhao
    Yuanyuan Zhu
    Yongxian Hu
    Wenjue Pan
    Yishan Ye
    Jingsong He
    Weiyan Zheng
    Jie Sun
    Zhen Cai
    He Huang
    Yi Luo
    Bone Marrow Transplantation, 2018, 53 : 1340 - 1344
  • [49] Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation
    Gilliland, DG
    Gribben, JG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (01) : 9 - 16
  • [50] Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
    Yang, Luxin
    Tan, Yamin
    Shi, Jimin
    Zhao, Yanmin
    Zhu, Yuanyuan
    Hu, Yongxian
    Pan, Wenjue
    Ye, Yishan
    He, Jingsong
    Zheng, Weiyan
    Sun, Jie
    Cai, Zhen
    Huang, He
    Luo, Yi
    BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1340 - 1344
12345